Compare BNZI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNZI | AIMD |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6M | 10.2M |
| IPO Year | N/A | N/A |
| Metric | BNZI | AIMD |
|---|---|---|
| Price | $1.01 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 395.5K | 24.7K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,650,176.00 | $113,037.00 |
| Revenue This Year | $205.97 | N/A |
| Revenue Next Year | $31.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 147.06 | ★ 178.19 |
| 52 Week Low | $0.94 | $1.78 |
| 52 Week High | $27.00 | $5.00 |
| Indicator | BNZI | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.09 | 37.19 |
| Support Level | $0.94 | $1.94 |
| Resistance Level | $1.08 | $2.18 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 15.48 | 6.28 |
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.